Andrew Tym Hattersley
Hattersley, Andrew T.
Hattersley, Andrew
VIAF ID: 315223483 (Personal)
Permalink: http://viaf.org/viaf/315223483
Preferred Forms
-
100 0 _
‡a
Andrew Tym Hattersley
-
100 1 _ ‡a Hattersley, Andrew
-
100 1 _ ‡a Hattersley, Andrew T.
4xx's: Alternate Name Forms (5)
Works
| Title | Sources |
|---|---|
| Genetyka molekularna wkracza do kliniki cukrzycy : program edukacyjny : diabetologia |
|
| Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility |
|
| Lower Circulating B12 Is Associated with Higher Obesity and Insulin Resistance during Pregnancy in a Non-Diabetic White British Population |
|
| Markers of β-Cell Failure Predict Poor Glycemic Response to GLP-1 Receptor Agonist Therapy in Type 2 Diabetes |
|
| Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors |
|
| Maternal hypothyroxinaemia in pregnancy is associated with obesity and adverse maternal metabolic parameters |
|
| Maturity-onset diabetes of the young caused by a balanced translocation where the 20q12 break point results in disruption upstream of the coding region of hepatocyte nuclear factor-4alpha (HNF4A) gene. |
|
| Measurement of cord insulin and insulin-related peptides suggests that girls are more insulin resistant than boys at birth. |
|
| Mendelian randomization studies do not support a role for raised circulating triglyceride levels influencing type 2 diabetes, glucose levels, or insulin resistance |
|
| A Mendelian Randomization Study Provides Evidence That Adiposity and Dyslipidemia Lead to Lower Urinary Albumin-to-Creatinine Ratio, a Marker of Microvascular Function |
|
| Mesangiocapillary glomerulonephritis type 2 associated with familial partial lipodystrophy (Dunnigan-Kobberling syndrome). |
|
| Messenger RNA transcripts of the hepatocyte nuclear factor-1alpha gene containing premature termination codons are subject to nonsense-mediated decay |
|
| Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution |
|
| A meta-analysis of four European genome screens (GIFT Consortium) shows evidence for a novel region on chromosome 17p11.2-q22 linked to type 2 diabetes |
|
| Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes |
|
| Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry |
|
| A meta-analysis of the associations between common variation in the PDE8B gene and thyroid hormone parameters, including assessment of longitudinal stability of associations over time and effect of thyroid hormone replacement |
|
| A meta-analysis of thyroid-related traits reveals novel loci and gender-specific differences in the regulation of thyroid function |
|
| Meta-analysis of up to 622,409 individuals identifies 40 novel smoking behaviour associated genetic loci |
|
| Minireview: pharmacogenetics and beyond: the interaction of therapeutic response, beta-cell physiology, and genetics in diabetes |
|
| A Missense Mutation in PPP1R15B Causes a Syndrome Including Diabetes, Short Stature, and Microcephaly |
|
| Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features |
|
| Molecular genetics goes to the diabetes clinic. |
|
| Molecular reductions in glucokinase activity increase counter-regulatory responses to hypoglycemia in mice and humans with diabetes |
|
| Monogenic autoimmune diseases of the endocrine system |
|
| Most people with long-duration type 1 diabetes in a large population-based study are insulin microsecretors |
|
| A mutation (R826W) in nucleotide-binding domain 1 of ABCC8 reduces ATPase activity and causes transient neonatal diabetes |
|
| Mutations at the same residue (R50) of Kir6.2 (KCNJ11) that cause neonatal diabetes produce different functional effects |
|
| Mutations in PTF1A cause pancreatic and cerebellar agenesis |
|
| Mutations in the ABCC8 (SUR1 subunit of the K(ATP) channel) gene are associated with a variable clinical phenotype |
|
| Mutations in the glucokinase gene of the fetus result in reduced placental weight |
|
| Mutations in the hepatocyte nuclear factor-1β (HNF1B) gene are common with combined uterine and renal malformations but are not found with isolated uterine malformations. |
|
| Mutations in the VNTR of the carboxyl-ester lipase gene (CEL) are a rare cause of monogenic diabetes |
|
| Mutations of the same conserved glutamate residue in NBD2 of the sulfonylurea receptor 1 subunit of the KATP channel can result in either hyperinsulinism or neonatal diabetes |
|
| Necrobiosis lipodica is a clinical feature of maturity-onset diabetes of the young |
|
| Neonatal diabetes as an isolated manifestation of ipex: an expanding spectrum of disease phenotype with FOXP3 mutation |
|
| Neonatal diabetes caused by a homozygous KCNJ11 mutation demonstrates that tiny changes in ATP sensitivity markedly affect diabetes risk |
|
| Neonatal diabetes in Ukraine: incidence, genetics, clinical phenotype and treatment. |
|
| Neonatal diabetes mutations disrupt a chromatin pioneering function that activates the human insulin gene |
|
| Neurogenin 3 is important but not essential for pancreatic islet development in humans |
|
| New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk |
|
| New genetic loci link adipose and insulin biology to body fat distribution |
|
| New loci associated with birth weight identify genetic links between intrauterine growth and adult height and metabolism |
|
| Niske doze sulfonilureje kao uspješna zamjena za inzulin u liječenju neonatalnog dijabetesa uzrokovanog aktivirajućom mutacijom KIR6.2. |
|
| A novel GATA6 mutation leading to congenital heart defects and permanent neonatal diabetes: a case report. |
|
| Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals |
|
| Novel loci for childhood body mass index and shared heritability with adult cardiometabolic traits |
|
| Optimisation of an Advanced Oxidation Protein Products Assay: Its Application to Studies of Oxidative Stress in Diabetes Mellitus |
|
| Origin of de novo KCNJ11 mutations and risk of neonatal diabetes for subsequent siblings |
|
| Pancreas and gallbladder agenesis in a newborn with semilobar holoprosencephaly, a case report. |
|
| Paradoxical lower serum triglyceride levels and higher type 2 diabetes mellitus susceptibility in obese individuals with the PNPLA3 148M variant |
|
| Parental diabetes and birthweight in 236 030 individuals in the UK biobank study |
|
| Permanent Neonatal Diabetes and Enteric Anendocrinosis Associated With Biallelic Mutations in NEUROG3. |
|
| Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects |
|
| Permanent neonatal diabetes: combining sulfonylureas with insulin may be an effective treatment |
|
| Permanent neonatal diabetes: different aetiology in Arabs compared to Europeans. |
|
| Permanent neonatal diabetes due to paternal germline mosaicism for an activating mutation of the KCNJ11 Gene encoding the Kir6.2 subunit of the beta-cell potassium adenosine triphosphate channel |
|
| Permanent neonatal diabetes in siblings with novel C109Y INS mutation transmitted by an unaffected parent with somatic mosaicism |
|
| Permanent neonatal diabetes mellitus: prevalence and genetic diagnosis in the SEARCH for Diabetes in Youth Study |
|
| Permanent neonatal diabetes misdiagnosed as type 1 diabetes in a 28-year-old female: a life-changing diagnosis. |
|
| Persistent C-peptide is associated with reduced hypoglycaemia but not HbA1c in adults with longstanding Type 1 diabetes: evidence for lack of intensive treatment in UK clinical practice? |
|
| Persistent hyperinsulinemic hypoglycemia and maturity-onset diabetes of the young due to heterozygous HNF4A mutations |
|
| Persistently autoantibody negative (PAN) type 1 diabetes mellitus in children. |
|
| Pharmacogenomics in diabetes: outcomes of thiamine therapy in TRMA syndrome. |
|
| Phenotypic severity of homozygous GCK mutations causing neonatal or childhood-onset diabetes is primarily mediated through effects on protein stability |
|
| Phosphodiesterase 8B Gene Polymorphism Is Associated with Subclinical Hypothyroidism in Pregnancy |
|
| Physiology Helps GWAS Take a Step Closer to Mechanism |
|
| Pigmentary retinal dystrophy and the syndrome of maternally inherited diabetes and deafness caused by the mitochondrial DNA 3243 tRNALeu A to G mutation11The authors have no proprietary interest in the development or marketing of any device or medica |
|
| PLIN1 Haploinsufficiency Is Not Associated With Lipodystrophy |
|
| A powerful approach to sub-phenotype analysis in population-based genetic association studies |
|
| A principal component meta-analysis on multiple anthropometric traits identifies novel loci for body shape |
|
| A putative functional polymorphism in the IGF-I gene: association studies with type 2 diabetes, adult height, glucose tolerance, and fetal growth in U.K. populations |
|
| A reference panel of 64,976 haplotypes for genotype imputation |
|
| A study of association between common variation in the growth hormone-chorionic somatomammotropin hormone gene cluster and adult fasting insulin in a UK Caucasian population |
|
| A successful transition to sulfonylurea treatment in male infant with neonatal diabetes caused by the novel abcc8 gene mutation and three years follow-up |
|
| A type 1 diabetes genetic risk score can discriminate monogenic autoimmunity with diabetes from early-onset clustering of polygenic autoimmunity with diabetes. |
|
| A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin |
|
| Variation in the calpain-10 gene affects blood glucose levels in the British population |
|
| Variation within the type 2 diabetes susceptibility gene calpain-10 and polycystic ovary syndrome |
|
| What to do with diabetes therapies when HbA1c lowering is inadequate: add, switch, or continue? A MASTERMIND study |
|
| Wolcott-Rallison syndrome is the most common genetic cause of permanent neonatal diabetes in consanguineous families |
|
| Young-onset type 2 diabetes families are the major contributors to genetic loci in the Diabetes UK Warren 2 genome scan and identify putative novel loci on chromosomes 8q21, 21q22, and 22q11. |
|
